/stocks — the workspaceLOADING
Leef Brands Inc. (LEEEF) is a medicinal chemicals & botanical products company. Piotroski F-Score 5/8. 3 insider Form 4 filings in the last 90 days. Fundamentals from SEC filings; prices are end-of-day.
What’s behind LEEEF’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Has LEEEF been issuing shares? Offering history →
FY ending 2025-12-31 vs 2024-12-31.
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from LEEEF’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
A plain-English read on LEEEF plus an auto-SWOT — built from LEEEF's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate LEEEF using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Projected from LEEEF's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentLEEEF files or announces.
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| Wilson Kevin JohnChief Financial Officer | BUY | $107K | view → |
| Anderson Micah PayneChief Executive Officer | BUY | $34K | view → |
| Wilson Kevin JohnChief Financial Officer | BUY | $14K | view → |
From SEC Form 4 and 13F filings. Both are backward-looking disclosures on different reporting clocks, and neither predicts price. Educational information only — not investment advice.